OFLOXACIN TABLETS

Država: Kanada

Jezik: angleščina

Source: Health Canada

Kupite ga zdaj

Lastnosti izdelka Lastnosti izdelka (SPC)
21-07-2015

Aktivna sestavina:

OFLOXACIN

Dostopno od:

AA PHARMA INC

Koda artikla:

J01MA01

INN (mednarodno ime):

OFLOXACIN

Odmerek:

400MG

Farmacevtska oblika:

TABLET

Sestava:

OFLOXACIN 400MG

Pot uporabe:

ORAL

Enote v paketu:

100

Tip zastaranja:

Prescription

Terapevtsko območje:

QUINOLONES

Povzetek izdelek:

Active ingredient group (AIG) number: 0122759002; AHFS:

Status dovoljenje:

CANCELLED POST MARKET

Datum dovoljenje:

2016-08-02

Lastnosti izdelka

                                0
PRODUCT MONOGRAPH
OFLOXACIN TABLETS
HOUSE STANDARD
200 MG, 300 MG AND 400 MG
ANTIBACTERIAL AGENT
AA PHARMA INC.
DATE OF REVISION:
1165 CREDITSTONE ROAD, UNIT #1
JULY 20, 2015
VAUGHAN, ONTARIO
L4K 4N7
Control#: 183164
1
PRODUCT MONOGRAPH
OFLOXACIN TABLETS
House Standard
200 mg, 300 mg and 400 mg
THERAPEUTIC CLASSIFICATION
Antibacterial Agent
ACTIONS AND CLINICAL PHARMACOLOGY
Ofloxacin is a broad–spectrum, synthetic fluoroquinolone
antibacterial agent for oral
administration.
Ofloxacin is thought to exert a bactericidal effect on susceptible
bacterial cells by inhibiting the
essential bacterial enzyme DNA gyrase, a critical catalyst in the
duplication, transcription and
repair of bacteria.
The bioavailability of ofloxacin in the tablet formulation is
approximately 98%. Ofloxacin is rapidly
and completely absorbed from the upper small bowel following oral
administration. The
pharmacokinetic parameters of ofloxacin following single doses of 200,
300 and 400 mg and
multiple doses of 400 mg to healthy males are summarized below.
Dose
C
max
µg/mL

S.D.
AUC
0-last point
µg x hr/mL

S.D.
T
max

S.D.
t
½
200 mg -single dose
1.7

0.3
14.1

2.3
1.5

0.3
4.9
300 mg -single dose
2.6

0.4
21.2

2.5
1.7

0.5
4.6
400 mg -single dose
3.7

0.7
31.4

4.7
1.8

0.6
3.8
400 mg -steady state
5.0

1.0
62.9

14.5
1.7

0.5
5.2
Elimination is mainly by renal excretion. Ofloxacin undergoes minimal
biotransformation.
2
Comparative Bioavailability
A comparative bioavailability study was performed using healthy human
volunteers. The rate and
extent of absorption of ofloxacin was measured and compared following
a single oral 400 mg
dose (one 400 mg tablet) of either OFLOXACIN TABLETS or Floxin. The
results from measured
data are summarized as follows:
Geometric Mean
Arithmetic Mean (CV%)
Parameter
OFLOXACIN
TABLETS
Floxin
†
Ratio of
Means (%)*
AUC
T
30.9
31.0
99.5
(µg
•
hr/mL)
31.7 (22)
31.7 (21)
AUC
I
33.3
33.2
100.0
(µg
•
hr/mL)
34.2 (23)
34.1 (22)
C
max
3.75
3.69
102.4
(µg/mL)
3.82 
                                
                                Preberite celoten dokument
                                
                            

Dokumenti v drugih jezikih

Lastnosti izdelka Lastnosti izdelka francoščina 17-08-2015

Opozorila o iskanju, povezana s tem izdelkom

Ogled zgodovine dokumentov